Trials / Completed
CompletedNCT00045877
Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Chiron Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the safety and effectiveness of combination therapy with Proleukin and Rituxan on patients with low-grade Non-Hodgkin's Lymphoma who have previously failed Rituxan treatments.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Recombinant Human Interleukin-2 and Rituximab |
Timeline
- First posted
- 2002-09-16
- Last updated
- 2006-02-06
Locations
65 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00045877. Inclusion in this directory is not an endorsement.